There are also reports in the literature that the decrease in Ki67 expression after neoadjuvant chemotherapy is related to the decrease in the number of cancer cells and tumor shrinkage during neoadjuvant chemotherapy, and the expression of Ki67 in residual cancer cells can predict the prognosis of patients [19]. This evidence concerns the gene MKI67 and neoplasm.